The global Anti-biofilm Wound Dressing market demand is expected to increase at a 9.5% CAGR between 2023 and 2033, from US$ 782.60 million in 2023 to more than US$ 1939.45 million by 2033. The prevalence of chronic and acute wounds is expected to rise in the coming years, increasing the demand for Anti-biofilm Wound Dressings.
Tobacco and alcohol use, as well as antibiotic resistance and unhealthy sedentary lifestyles, all contribute to the growing burden of noncommunicable disease. This is because chronic diseases such as diabetes, cancer, and autoimmune diseases are becoming more common.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16474
Other factors impacting market growth include the expansion of developing-country healthcare infrastructure and technical advancements in wound care. Wound care promotion activities by healthcare providers and other critical parties.
“Telehealth has played a key role in the strong recovery of the wound care market. Various healthcare providers have developed telehealth platforms to effectively manage patients with chronic and acute wounds.” says a lead analyst at Future Market Insights.
Key Takeaways from Market Study
- Over the forecast period, the market for Anti-biofilm Wound Dressing is expected to grow at a CAGR of 9.5%.
- According to projections, the Anti-biofilm Wound Dressing market in North America will remain robust throughout the duration of the forecast period.
- The acute wound segment dominated the market and is predicted to grow at a 9.3% CAGR.
Competitive Landscape
Several prominent companies dominate this market, including ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, and 3M.
Anti-biofilm Wound Dressing has developed significantly in the industry through partnerships, acquisitions, and research and development. These strategies have resulted in major developments.
Speak to Our Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16474
Recent Developments:
- Convatec Inc. paid US$ 450 million for Triad Life Sciences Inc. in March 2022. This acquisition was made to expand the company’s portfolio of biomedical solutions for surgical and chronic wounds.
- In April 2021, the FDA approved Imbed Biosciences’ antimicrobial matrix product, Microlyte Matrix. The product is suitable for treating surgical, traumatic, and chronic wounds.
- ConvaTec Group Plc (ConvaTec) developed a new medicine called “ConvaMax” in January 2020 for the treatment of diabetic foot ulcers, pressure ulcers, leg ulcers, and dehisced surgical wounds. The solution is also available in non-adhesive versions, providing for complete flexibility when it comes to incorporating compression bands and other major dressings.
- In January 2018, Imbed Biosciences introduced the market with Microlyte Ag after raising over US$ 1.6 million to research silver-based Anti-biofilm Wound Dressings.
- As a result of this acquisition, Smith & Nephew PLC expanded its product portfolio for advanced wound management, increasing its market share and customer base. In April 2019, the company acquired Osiris Therapeutics, Inc., a regenerative medicine company. As a result of this acquisition, the company will boost its growth by expanding its product portfolio for advanced wound management.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16474
Anti-biofilm Wound Dressing Market Segmentation by Category
By Mode of Mechanism:
- Physical
- Chemical
- Biological
By Wound Type:
- Chronic Wounds
- Acute Wounds
By End User:
- Hospitals and Clinics
- Surgical Centers
- Other End users
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs